What is jc virus

Last updated: April 1, 2026

Quick Answer: JC virus is a common polyomavirus that infects most people asymptomatically, but can cause progressive multifocal leukoencephalopathy (PML), a rare and serious brain disease in people with severely weakened immune systems.

Key Facts

Overview

JC virus is a human polyomavirus that is extremely common in the general population. Named after John Cunningham, the first patient definitively diagnosed with PML in 1971, JC virus typically remains dormant in kidney cells and causes no symptoms in healthy individuals.

Infection and Prevalence

JC virus is widespread globally, with approximately 80% of people becoming infected by age 10. Infection is generally thought to occur through respiratory or urinary routes, though the exact transmission mechanism is not completely understood. The virus is acquired early in life and remains in the body indefinitely once infected.

Asymptomatic Infection

In healthy individuals with normal immune function, JC virus infection causes no symptoms or detectable illness. The virus remains latent in kidney epithelial cells and other tissues. People can unknowingly carry and potentially shed JC virus without experiencing any health problems. Most infected people never develop disease related to JC virus.

Progressive Multifocal Leukoencephalopathy (PML)

PML is a serious opportunistic infection of the brain that occurs when JC virus reactivates in severely immunocompromised individuals. The virus destroys oligodendrocytes, the cells that produce myelin and insulate nerve fibers in the brain. This causes progressive neurological deterioration including cognitive decline, weakness, vision loss, and speech problems. PML typically affects people with CD4+ counts below 50 cells/μL in HIV/AIDS patients.

Risk Groups and Associations

PML risk groups include individuals with advanced HIV/AIDS (especially before widespread antiretroviral therapy), patients on certain immunosuppressive drugs for autoimmune conditions, and recipients of bone marrow or organ transplants. Recent cases have been associated with monoclonal antibody therapies and JAK inhibitors used to treat rheumatologic conditions.

Diagnosis and Management

PML diagnosis typically involves MRI findings showing white matter lesions, detection of JC virus in cerebrospinal fluid via PCR, and brain biopsy in some cases. There is no cure for PML. Treatment focuses on immune system restoration through antiretroviral therapy in HIV patients or discontinuation of immunosuppressive medications. Some antiviral agents are being investigated but have limited efficacy.

Related Questions

What is progressive multifocal leukoencephalopathy (PML)?

PML is a rare, serious brain infection caused by JC virus reactivation in severely immunocompromised people. It causes progressive neurological decline as the virus damages brain cells, leading to cognitive problems, weakness, and vision loss. PML has high mortality if immune function is not restored.

What is the difference between JC virus and other polyomaviruses?

JC virus is one of several human polyomaviruses including BK virus and Merkel cell polyomavirus. While BK virus primarily causes kidney disease in transplant patients, JC virus specifically targets the brain and causes PML in immunocompromised individuals. Each has distinct clinical manifestations and risk populations.

How do you catch JC virus and is it contagious?

JC virus is likely transmitted through respiratory droplets or urine, typically during childhood, and most people become infected by age 10. Infected people can shed virus in urine, but transmission to others is not well documented, and the virus is not considered highly contagious.

Can JC virus be transmitted person-to-person?

JC virus transmission between individuals is rare in normal circumstances. Primary infection likely occurs through respiratory droplets, but the virus then becomes latent. Person-to-person transmission of active PML infection does not occur, making PML non-contagious.

Who is at risk for JC virus complications?

People at highest risk for PML include those with advanced HIV/AIDS (CD4 count below 50), patients on immunosuppressive medications for autoimmune diseases, organ transplant recipients, and those taking monoclonal antibodies or JAK inhibitors. Risk is dramatically reduced with immune system recovery.

Is there a cure for progressive multifocal leukoencephalopathy (PML)?

Currently, no specific cure for PML exists. Treatment focuses on immune reconstitution, particularly restoring CD4 counts in HIV patients through antiretroviral therapy. In some cases, patients achieve remission through immune recovery, though many experience permanent neurological damage.

Sources

  1. CDC - JC Virus Information CC0
  2. NIH NINDS - Progressive Multifocal Leukoencephalopathy CC0
  3. Wikipedia - JC Virus CC-BY-SA-4.0